title: Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis?
authors.forename: Shoichi
authors.initials: S
authors.lastname: Inaba
authors.forename: Kensuke
authors.initials: K
authors.lastname: Egashira
authors.forename: Kimihiro
authors.initials: K
authors.lastname: Komori
mesh_terms: D000368:Aged; D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use*; D018952:Antigens, CD34 / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000628:therapy*; D001781:Blood Component Removal; D016026:Bone Marrow Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D043925:Angiogenesis Inducing Agents; D018952:Antigens, CD34